Gene Therapy for Mesothelioma

OncoLink Team
The Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 7 de mayo del 2013

Share article


What results are you seeing in using gene therapy to treat mesothelioma?


Dan Sterman, MD, Interventional Pulmonologist at Penn Medicine, responds:

The results of gene therapy trials for mesothelioma to date (from 1995 to the present) have shown that the delivery methods are safe, that we can get expression of the therapeutic genes within the tumor cells, and that we can induce some anti-tumor responses. The trials to date, however, have all been in the Phase I trials. Therefore, response rates, increases in survival, and other crucial questions still will await final analysis of current Phase II and future Phase III clinical trials.

You may be interested in Dr. Sterman's presentation about gene therapy for mesothelioma at the 2012 Focus on Mesothelioma conference.

This question and answer was part of the OncoLink Brown Bag Chat Series. View the entire Focus on Mesothelioma transcript.

Radical pleurectomy, photodynamic therapy improve malignant pleural mesothelioma outcome

Jun 14, 2011 - Patients with malignant pleural mesothelioma who are treated with radical pleurectomy and intraoperative photodynamic therapy have improved overall survival compared to those treated with modified extrapleural pneumonectomy, according to a study published in the June issue of The Annals of Thoracic Surgery.

I Wish You Knew

What is Photodynamic Therapy and how is it used in cancer care?

View More

Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.

OncoLink OncoPilot

Frente a un nuevo diagnóstico de cáncer o de cambiar el curso de su tratamiento actual? Deje que nuestro personal de enfermería cáncer que ayudan a pasar!

Más información